A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
- 23 March 2011
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 12 (4) , 377-386
- https://doi.org/10.1016/s1470-2045(11)70044-4
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinomaNature, 2009
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancersCarcinogenesis: Integrative Cancer Research, 2009
- A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non–Small Cell Lung Cancer RiskCancer Research, 2008
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001